Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Heidi C. E. Welch
Based on 4 articles published since 2009
(Why 4 articles?)
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 4 published articles on Melanoma from 2009 through 2019, it is not possible for Expertscape to reliably rate Heidi C. E. Welch's expertise on this topic.

Aliases Welch, Heidi C   ·   Welch, Heidi C E
Work Locations
Details
Most likely:    Babraham Institute      
2016
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborate Center for Cancer Medicine, Guangzhou 510060, China; · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, TX 77030; · The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, United Kingdom; · Division of Biological and Environmental Sciences and Engineering, King Abdullah University of Science and Technology, Thuwal, 23955-6900 Saudi Arabia; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Broad Institute of MIT and Harvard, Boston, MA 02141. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Pubmed 26884185
2014
  • Inositide laboratory, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK. · Lineberger Comprehensive Cancer Center and Department of Pharmacology, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, North Carolina, USA. · Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan. · Inositide laboratory, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK · Pubmed 24659802
Possible:    University of Glasgow      
2013
  • Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. · Pubmed 23382862
2011
  • The Beatson Institute for Cancer Research, Glasgow G61 1BD, UK. · Pubmed 22109529
Possible:    NHS Greater Glasgow and Clyde      
2013
  • Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. · Pubmed 23382862
2011
  • The Beatson Institute for Cancer Research, Glasgow G61 1BD, UK. · Pubmed 22109529
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Heidi C. E. Welch in 2009-2019 about Melanoma:

  • Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma. 2016
  • P-Rex1 directly activates RhoG to regulate GPCR-driven Rac signalling and actin polarity in neutrophils. 2014
  • P-Rex1 cooperates with PDGFRβ to drive cellular migration in 3D microenvironments. 2013
  • P-Rex1 is required for efficient melanoblast migration and melanoma metastasis. 2011
Show List of Full Article Records
Google Searches

Learn more about Heidi C. E. Welch using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Babraham Institute
University of Glasgow
NHS Greater Glasgow and Clyde
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Babraham Institute
2016
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborate Center for Cancer Medicine, Guangzhou 510060, China; · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, TX 77030; · The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, United Kingdom; · Division of Biological and Environmental Sciences and Engineering, King Abdullah University of Science and Technology, Thuwal, 23955-6900 Saudi Arabia; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Broad Institute of MIT and Harvard, Boston, MA 02141. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Pubmed 26884185
2014
  • Inositide laboratory, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK. · Lineberger Comprehensive Cancer Center and Department of Pharmacology, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, North Carolina, USA. · Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan. · Inositide laboratory, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK · Pubmed 24659802
University of Glasgow
2013
  • Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. · Pubmed 23382862
2011
  • The Beatson Institute for Cancer Research, Glasgow G61 1BD, UK. · Pubmed 22109529
NHS Greater Glasgow and Clyde
2013
  • Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. · Pubmed 23382862
2011
  • The Beatson Institute for Cancer Research, Glasgow G61 1BD, UK. · Pubmed 22109529
Yearly article counts 00010110100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.